Solid Biosciences Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -25.21M-54.64M-75.07M-117.74M-88.29M-72.19M-103.84M-97.11M-120.60M
Depreciation and Depletion 0.06M0.45M1.57M2.82M3.92M2.96M2.41M2.58M
Share-based Compensation 1.47M5.33M5.96M14.21M11.63M13.37M7.54M7.62M10.52M
Gains from Sales and Divestitures 3.42M0.33M0.34M0.41M0.42M0.18M
Gains from Investment Securities -1.16M-0.46M1.15M2.61M3.12M0.40M1.43M2.26M0.41M
Non-cash Items 0.40M1.09M0.20M0.62M
Cash from Operations -20.12M-43.22M-70.20M-92.71M-56.60M-77.76M-97.98M-94.18M-100.01M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.51M-0.21M0.09M0.28M0.02M-1.12M-0.23M2.41M3.59M
Depreciation & Amortization (CF) 0.06M0.45M1.57M2.82M3.92M2.96M2.41M2.58M2.46M
Change in Working Capital
Change in Receivables 0.11M-0.11M
Change in Account Payables 2.21M1.58M-1.61M3.78M-3.43M1.21M-5.25M-0.76M2.21M
Change in Accured Expenses 2.58M2.04M2.88M-0.51M-1.16M-2.25M5.83M-6.97M4.77M
Other Working Capital Changes 2.00M-0.81M4.93M-4.49M20.72M-12.64M0.04M0.05M2.44M
Investing Activities
Capital Expenditures 0.39M2.28M7.78M4.39M0.90M1.28M3.02M1.51M0.65M
Sales of Property, Plant and Equipment 0.60M0.01M
Cash from Investing Activities -4.05M10.45M-26.76M24.52M6.60M-91.09M59.16M9.69M-16.09M
Financing Activities
Other financing activities 2.42M2.17M2.10M3.79M5.11M
Cash from Financing Activities 3.42M77.08M131.51M57.88M128.70M134.99M74.83M3.12M122.44M
Change in Capital Stock
Net Equity Issued and Repurchased 55.00M
Additional items
Change in Cash -20.75M44.30M34.55M-10.32M78.70M-33.87M36.01M-81.37M6.34M
Free Cash Flow -20.51M-45.50M-77.97M-97.10M-57.50M-79.05M-100.99M-95.69M-100.67M
Net Cash Flow -20.75M44.30M34.55M-10.32M78.70M-33.87M36.01M-81.37M6.34M